GoldBamboo.com - Knowledge is strong medicine
  

Weight Gain Prevention in Hypertensive Smokers - Article


  Not Signed In - Sign In / Register






Obesity and Weight Management


Clinical Trial: Weight Gain Prevention in Hypertensive Smokers

This study is currently recruiting patients.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

To evaluate a smoking cessation program, followed by lifestyle modification, to prevent weight gain among hypertensive smokers placed at medical risk by this post-cessation weight gain.
Condition Intervention
Cardiovascular Diseases
Heart Diseases
Hypertension
Obesity
 Behavior: weight reducing diet
 Behavior: exercise
 Behavior: smoking cessation

MedlinePlus related topics:  Heart Diseases;   High Blood Pressure;   Obesity;   Vascular Diseases

Study Type: Interventional
Study Design: Prevention, Randomized

Further Study Details: 

Study start: September 2004;  Expected completion: August 2009

BACKGROUND: Obesity and smoking are major risk factors for a variety of health-related disorders, such as heart disease, stroke, certain forms of cancer, and diabetes. Recently, it has been reported that up to 65 percent of adult Americans are overweight or obese. The increasing epidemic of obesity has led to many initiatives to treat obesity and to a number of recent initiatives to prevent weight gain. Similarly, the prevalence of smoking has not declined in the past few years, despite several effective and cost-effective smoking cessation programs. One unwanted effect of smoking cessation is weight gain, which may exacerbate weight-related health issues. Behavioral (and pharmacological, to a lesser degree) programs designed to reduce this post-cessation weight gain have met with some success. However, given that this weight gain is typically cosmetic, it has been concluded that such programs should be targeted to those at higher medical risk as a result of the weight gain (e.g., hypertensives). To our knowledge, no study has evaluated a smoking cessation program, followed by lifestyle modification, to prevent weight gain among those placed at medical risk by this post-cessation weight gain. A population clearly at medical risk following smoking cessation (and the resultant weight gain) are those with hypertension. Some studies find an increased prevalence of hypertension following cessation . It is believed that this is largely (but not solely) due to weight gain following cessation. However, any weight gain in those with hypertension places them at risk. Body weight is the single best predictor of adult blood pressure, and blood pressure responds to very small changes in overall body weight.

DESIGN NARRATIVE: The objectives are 1) to recruit a sample of 660 smokers with hypertension or elevated blood pressure (high normal by JNC VI criteria). Given that Blacks are at high risk for both post-cessation weight gain and hypertension, the majority of the cohort recruited will be Black; and (2) To randomize participants to: (a) a validated smoking cessation program followed by a validated weight control program (TONE) consisting of changes in dietary intake and physical activity; or (b) the same smoking cessation intervention followed by a general health education (contact-time control) program. Primary endpoints include smoking cessation and body weight changes at a 1-year follow-up. Secondary endpoints include changes in dietary intake and physical activity. Exploratory endpoints include changes in blood pressure and hypertensive status in both groups (e.g., movement from high normal to hypertensive by JNC VI criteria), as well as changes in blood pressure medication status and salt intake.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria
No eligibility criteria

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00119821


Minnesota
      Mayo Clinic College of Medicine, Rochester,  Minnesota,  55905,  United States; Recruiting
Robert C. Klesges, Ph.D.  507-266-1092    Klesges.Bob@mayo.edu 
Robert C. Klesges,  Study Chair

Study chairs or principal investigators

Robert Klesges,  Mayo Clinic College of Medicine   

More Information

Study ID Numbers:  225
Record last reviewed:  June 2005
Last Updated:  July 18, 2005
Record first received:  July 14, 2005
ClinicalTrials.gov Identifier:  NCT00119821
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-07-26


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Obesity and Weight Management.

September 8, 2008



Page Updated: December 9, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.